(本图为广告,与下文无关)核心看点2025年11月总览:2025年11月,中国农药原药新增拟建/投产产能约4.5万吨,保持高位活跃;热点:次新化合物聚焦——氟吡菌酰胺(12家)、二氯异恶草酮(3家);明星:啶氧菌酯作为成熟杀菌剂明星品种,市场表现稳健,近年来在中国、印度投资热度较高;风险:多个热门品种已形成″万吨级″拟建产能集群,需警惕未来产能集中释放带来的市场过剩风险。根据AgroPages世界...
Source Link(本图为广告,与下文无关)核心看点2025年11月总览:2025年11月,中国农药原药新增拟建/投产产能约4.5万吨,保持高位活跃;热点:次新化合物聚焦——氟吡菌酰胺(12家)、二氯异恶草酮(3家);明星:啶氧菌酯作为成熟杀菌剂明星品种,市场表现稳健,近年来在中国、印度投资热度较高;风险:多个热门品种已形成″万吨级″拟建产能集群,需警惕未来产能集中释放带来的市场过剩风险。根据AgroPages世界...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.